 CAMBRIDGE, Mass., Sept. 07, 2022 GLOBE NEWSWIRE -- Cullinan Oncology, Inc. Nasdaq: CGEM Cullinan Oncology a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today announced that Company management will participate in the following investor conferences: 